Increasing HIV prevention access for Black women
Trauma-Informed HIV Prevention for Black Women in Baltimore
NA · Johns Hopkins Bloomberg School of Public Health · NCT06703060
This study is testing a new way to help Black women in Baltimore start taking HIV prevention medication by providing support and resources to overcome challenges they face.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Johns Hopkins Bloomberg School of Public Health (other) |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT06703060 on ClinicalTrials.gov |
What this trial studies
This study aims to implement a multi-level intervention designed to enhance the initiation of pre-exposure prophylaxis (PrEP) among Black women in Baltimore, who are at high risk for HIV. The intervention addresses socio-structural barriers such as intimate partner violence and gendered racism that hinder access to PrEP. By utilizing peer navigation groups, the study seeks to provide support and resources to facilitate PrEP initiation among participants. The effectiveness, implementation, and sustainability of this approach will be assessed throughout the study.
Who should consider this trial
Good fit: Ideal candidates for this study are self-identified Black cisgender women who are HIV-negative, at least 18 years old, and have reported unprotected sex with male partners along with substantial HIV risk factors.
Not a fit: Patients who are non-English speaking or currently living with HIV will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase PrEP initiation rates among Black women, thereby reducing their risk of HIV infection.
How similar studies have performed: While there is limited research specifically targeting this demographic with a multi-level intervention, similar studies have shown promise in addressing barriers to PrEP access in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * self-identified Black cisgender woman; * self-reported HIV-negative status, and * ≥18 years. * reports unprotected vaginal or anal sex in the past 6 months with a male sexual partner, * have at least one substantial HIV risk factor in the past 6 months according to the 2021 Centers for Disease Control (CDC) PrEP Eligibility Guidelines (i.e., HIV-positive sexual partner, recent bacterial Sexually Transmitted Disease (STD), 2+ sex partners, history of inconsistent or no condom use, commercial sex work, and residing in high HIV prevalence area or network), and * never taken PrEP Exclusion Criteria: * non-English speaking and * currently living with HIV
Where this trial is running
Baltimore, Maryland
- Johns Hopkins Bloomberg School of Public Health — Baltimore, Maryland, United States (RECRUITING)
Study contacts
- Principal investigator: Tiara C. Willie, PhD, MA — Johns Hopkins Bloomberg School of Public Health
- Study coordinator: Tiara C. Willie, PhD, MA
- Email: twillie2@jhu.edu
- Phone: 410-614-2686
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: HIV Prevention, PrEP, Women, Intimate Partner Violence